Company website
- is launching a public issue worth ₹0 crore. The offer includes a fresh issue of ₹0 crore and an offer for sale (OFS) of ₹0 crore. Together, this brings the total number of shares issued to - shares.
IPO opens on — and closes on —. After the bidding ends, the allotment is expected to be declared on —. The company is proposed to be listed on BSE and NSE, with a tentative listing date of —.
Start Date—
End Date—
Listing Date—
Allotment Date—
Current Price₹0
GMP-
Lot Sizeundefined Shares
Subscriptionundefined Times
Face Valueundefined
Listing atundefined
Issue Priceundefined
Pre Issue₹0
Post Issue₹0
Issue Size-
Fresh Issue-
Offer For Sale-
The Grey Market Premium (GMP) for is currently around -. This indicates an estimated listing price of approximately ₹NaN based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
03 Apr 2025, 08:18
₹0
₹40
₹40 (0.00%)
Below you can find the official contact details of along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Email: —
Phone: —
Website: —
Address: —

IPO Registrar

Name: —
Phone: —
Email: —
Website: —

About Company

Our organization excels in various areas and offers a wide range of services...

Strength Factors

  1. Prominent Market Position with a Diverse Product Offering:A top producer in the fields of medicine, food, nutrition, and unique ingredients (as of June 30, 2025), with a significant focus on mineral-based offerings, iron phosphate, and a diverse array of specialized food ingredients, including encapsulated preservatives.
  2. State-of-the-Art and Fully Regulated Production Facilities:Runs four plants with 12 production lines located in Gujarat and Ireland, utilizing 68,446 square meters and providing an annual output of 72,246 MT, ensuring effective production processes and adherence to regulations.
  3. Progress Fueled by Strong R&D Expertise:Features two research and development centers and a team of 41 experts dedicated to particle technology, extending shelf life, improving nutrient absorption, and innovative formulation methods, bolstered by cutting-edge tools to foster advancements in technology, sustainability, and product development.

Risk Factors

  1. High Reliance on Important Clients:A significant portion of income relies on a small number of clients, which makes the company susceptible to a decrease in orders or the departure of any important customer, potentially affecting its financial health and cash flow.
  2. Stringent Regulations and Quality Standards:Production facilities are frequently evaluated and must adhere to guidelines set by international organizations like USFDA, EXCiPACT, FSSC, WHO-GMP, ISO, and HACCP. Any inconsistencies, quality issues, or failure to comply could trigger regulatory consequences and damage the firm’s image.
  3. Potential for Operational Interruptions:Production and research activities may encounter risks from equipment failures, workplace incidents, regulatory challenges, natural disasters, or disease outbreaks. Any interruptions or closures could adversely impact operations, financial outcomes, and cash availability.